AstraZeneca
AZN
#47
Rank
C$433.95 B
Marketcap
C$279.92
Share price
2.16%
Change (1 day)
53.90%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): C$8.30

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is C$8.11. In 2024 the company made an earnings per share (EPS) of C$6.21 an increase over its 2023 EPS that were of C$5.25.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$8.3033.78%
2024C$6.2118.23%
2023C$5.2581.13%
2022C$2.90631.03%
2021C$0.40-88.11%
2020C$3.33136.89%
2019C$1.41-39.41%
2018C$2.32-28.27%
2017C$3.24-14.37%
2016C$3.7824.11%
2015C$3.05127.55%
2014C$1.34-51.96%
2013C$2.79-58.95%
2012C$6.79-32.2%
2011C$10.02

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$15.22 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$9.84 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.86-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$5.13-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.47 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$2.82-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
C$12.07 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$9.99 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.73-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$5.15-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK